J. Fletcher

1.9k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

J. Fletcher is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, J. Fletcher has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in J. Fletcher's work include Gastrointestinal Tumor Research and Treatment (6 papers), Diabetes and associated disorders (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). J. Fletcher is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (6 papers), Diabetes and associated disorders (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). J. Fletcher collaborates with scholars based in United States, United Kingdom and France. J. Fletcher's co-authors include George D. Demetri, C. Tsao, Samuel Singer, M K Hibbard, David A. Tuveson, Anette Duensing, Brian P. Rubin, Marcia L. Lux, CDM Fletcher and Sheng Xiao and has published in prestigious journals such as Journal of Clinical Oncology, Diabetologia and The American Journal of Surgical Pathology.

In The Last Decade

J. Fletcher

35 papers receiving 1.4k citations

Hit Papers

KIT activation is a ubiquitous feature of gastrointestina... 2001 2026 2009 2017 2001 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
    2001 789 citations George D. Demetri, J. Fletcher et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Fletcher United States 15 669 662 381 249 166 36 1.4k
Edward L. Lee United States 21 330 0.5× 139 0.2× 502 1.3× 76 0.3× 274 1.7× 49 1.3k
Joseph P. Michalski United States 19 109 0.2× 160 0.2× 254 0.7× 304 1.2× 114 0.7× 36 1.1k
Monica Di Battista Italy 17 424 0.6× 308 0.5× 238 0.6× 20 0.1× 189 1.1× 40 810
Thomas Taylor White United States 25 317 0.5× 169 0.3× 962 2.5× 28 0.1× 202 1.2× 88 1.7k
Kazuhiko Fujii Japan 17 365 0.5× 92 0.1× 126 0.3× 60 0.2× 195 1.2× 63 921
Zsuzsanna Szalai Hungary 19 595 0.9× 135 0.2× 194 0.5× 214 0.9× 210 1.3× 51 2.5k
Ronald A. Welsh United States 16 458 0.7× 41 0.1× 288 0.8× 141 0.6× 166 1.0× 38 1.1k
Sara Szabo United States 17 364 0.5× 39 0.1× 130 0.3× 159 0.6× 208 1.3× 69 1.0k
Min Chan Kim South Korea 26 1.7k 2.5× 924 1.4× 854 2.2× 31 0.1× 280 1.7× 70 2.5k
K Kinoshita Japan 16 238 0.4× 59 0.1× 308 0.8× 72 0.3× 425 2.6× 65 1.2k

Countries citing papers authored by J. Fletcher

Since Specialization
Citations

This map shows the geographic impact of J. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Fletcher more than expected).

Fields of papers citing papers by J. Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Fletcher. The network helps show where J. Fletcher may publish in the future.

Co-authorship network of co-authors of J. Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of J. Fletcher. A scholar is included among the top collaborators of J. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Fletcher. J. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harcourt, Sally, J. Fletcher, Paul Loveridge, et al.. (2012). Developing a new syndromic surveillance system for the London 2012 Olympic and Paralympic Games. Epidemiology and Infection. 140(12). 2152–2156. 30 indexed citations
3.
Lee, Chi‐Hang, Adrián Mariño‐Enríquez, Matt van de Rijn, et al.. (2011). The Histologic Features of Endometrial Stromal Sarcomas Characterized by YWHAE Rearrangement - Distinction from Usual Low-Grade Endometrial Stromal Sarcoma with JAZF1 Rearrangement. Laboratory Investigation. 24. 2 indexed citations
4.
Janeway, Katherine A., Soo‐Chan Kim, Maya Lodish, et al.. (2010). Succinate dehydrogenase in KIT/PDGFRA wild-type gastrointestinal stromal tumors.. Journal of Clinical Oncology. 28(15_suppl). 10008–10008. 3 indexed citations
5.
Mühlenberg, Thomas, J. Fletcher, Florian Grabellus, Martin Schüler, & Sebastian Bauer. (2010). 211 Effective therapeutic sensitization of gastrointestinal stromal tumors by a BH3 mimetic. European Journal of Cancer Supplements. 8(7). 69–70. 1 indexed citations
6.
Gunaratnam, Mekala, et al.. (2007). Targeting imatinib-resistant gastrointestinal stromal tumors by down-regulation of KIT gene expression with quadruplex-stabilizing small molecules. UCL Discovery (University College London). 1 indexed citations
7.
8.
Evans, T. R. J., Annick D. Van den Abbeele, Iain McPherson, et al.. (2005). Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3034–3034. 26 indexed citations
9.
Zitvogel, Laurence, François Ghiringhelli, Magali Terme, et al.. (2005). A novel mode of antitumor activity for imatinib mesylate: Consequences for the design of surrogate markers of efficacy and combination therapies. Journal of Clinical Oncology. 23(16_suppl). 2516–2516. 3 indexed citations
10.
Pérez‐Atayde, Antonio R., Robert Newbury, J. Fletcher, R. L. Barnhill, & Stephen E. Gellis. (1994). A Possible Marker of Malignant Rhabdoid Tumor. The American Journal of Surgical Pathology. 18(10). 1030–1038. 20 indexed citations
11.
Fletcher, J., Cynthia C. Morton, K Pavelka, & Janice M. Lage. (1990). Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.. PubMed. 50(13). 4092–7. 57 indexed citations
12.
Woltering, Eugene A., Thomas M. O’Dorisio, J. Fletcher, et al.. (1990). Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with Sandostatin.. PubMed. 85(2). 181–8. 14 indexed citations
13.
Mijovic, C., David J.A. Jenkins, J. Fletcher, et al.. (1989). RACE-SPECIFIC DR-DQ HAPLOTYPES ALLOW FINER MAPPING OF GENETIC SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES. Diabetologia. 32. 3 indexed citations
14.
Rowe, Brian H., et al.. (1989). Diabetes in the UK West Indian Community: the Wolverhampton Survey. Diabetic Medicine. 6(1). 48–52. 16 indexed citations
15.
Mijovic, C., et al.. (1988). Immunoglobulin heavy chain phenotypes and background retinopathy in non-insulin dependent diabetics.. BMJ. 297(6656). 1104–1105. 8 indexed citations
16.
Mijovic, C., J. Fletcher, A.R. Bradwell, & A H Barnett. (1986). Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition.. BMJ. 292(6518). 433–435. 19 indexed citations
17.
Mijovic, C., J. Fletcher, A.R. Bradwell, Tim Harvey, & A H Barnett. (1985). Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications.. BMJ. 291(6487). 9–10. 22 indexed citations
18.
Barnett, A H, C. Mijovic, J. Fletcher, et al.. (1984). Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.. BMJ. 289(6450). 943–945. 26 indexed citations
19.
Fletcher, J., et al.. (1979). LONG TERM EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL IN MICE. Elsevier eBooks. 359–370. 2 indexed citations
20.
Fletcher, J., et al.. (1969). MECHANISM OF ACTION OF ACCELERANTS ON SKIN PENETRATION. British Journal of Dermatology. 81(s4). 47–55. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward L. Lee Breakdown of academic impact, for papers by Joseph P. Michalski Breakdown of academic impact, for papers by Monica Di Battista Breakdown of academic impact, for papers by Thomas Taylor White Breakdown of academic impact, for papers by Kazuhiko Fujii Breakdown of academic impact, for papers by Zsuzsanna Szalai Breakdown of academic impact, for papers by Ronald A. Welsh Breakdown of academic impact, for papers by Sara Szabo Breakdown of academic impact, for papers by Min Chan Kim Breakdown of academic impact, for papers by K Kinoshita
Rankless by CCL
2026